The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about ...

RFK Jr. turned the CDC's vaccine committee into an anti-vaccine panel, but it still heard evidence that his campaign against ...

By Dennis Thompson HealthDay ReporterTHURSDAY, June 26, 2025 (HealthDay News) — Updated COVID-19 vaccines are keeping up with ...

The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...

The Food and Drug Administration department of the US has updated its warning about rare heart risk associated with to ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

Peter Marks, who headed the FDA’s Center for Biologics Evaluation and Research before being forced to resign in March, said the agency’s new risk-based COVID-19 vaccine framework contradicts the ...

At the start of an unprecedented meeting of vaccine committee of the US Centers for Disease Control and Prevention, the ...

Two new Omicron subvariants are gaining ground in the U.S. as some people report experiencing respiratory symptoms like ...

In its discussions for the upcoming 2025-2026 respiratory virus season, the COVID vaccination workgroup of the Advisory Committee on Immunization Practices (ACIP) considered recommendations that all ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.